Chemoinformaics analysis of (2S)-5-HYDROXY-7-METHOXYFLAVANONE
Molecular Weight | 270.284 | nRot | 2 |
Heavy Atom Molecular Weight | 256.172 | nRig | 18 |
Exact Molecular Weight | 270.089 | nRing | 3 |
Solubility: LogS | -4.451 | nHRing | 1 |
Solubility: LogP | 3.41 | No. of Aliphatic Rings | 1 |
Acid Count | 0 | No. of Aromatic Rings | 2 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 34 | No. of Aliphatic Hetero Cycles | 1 |
No. of Heavy Atom | 20 | No. of Aromatic Carbocycles | 2 |
nHetero | 4 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 14 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 16 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 12 |
No. of Oxygen atom | 4 | No. of Arom Bond | 12 |
nHA | 4 | APOL | 39.2631 |
nHD | 1 | BPOL | 18.3849 |
QED | 0.911 |
Synth | 2.59 |
Natural Product Likeliness | 1.329 |
NR-PPAR-gamma | 0.934 |
Lipinski | Accepted |
Pfizer | Rejected |
GSK | Accepted |
Golden Triangle | Accepted |
Pgp-inh | 0.059 |
Pgp-sub | 0 |
HIA | 0.01 |
CACO-2 | -4.66 |
MDCK | 0.0000175 |
BBB | 0.27 |
PPB | 0.97067 |
VDSS | 0.532 |
FU | 0.0216526 |
CYP1A2-inh | 0.938 |
CYP1A2-sub | 0.831 |
CYP2c19-inh | 0.956 |
CYP2c19-sub | 0.453 |
CYP2c9-inh | 0.899 |
CYP2c9-sub | 0.928 |
CYP2d6-inh | 0.872 |
CYP2d6-sub | 0.86 |
CYP3a4-inh | 0.78 |
CYP3a4-sub | 0.234 |
CL | 9.462 |
T12 | 0.228 |
hERG | 0.047 |
Ames | 0.358 |
ROA | 0.5 |
SkinSen | 0.513 |
Carcinogencity | 0.541 |
EI | 0.938 |
Respiratory | 0.863 |
NR-Aromatase | 0.046 |
Antiviral | Yes |
Prediction | 0.707137 |